The DOI matches its Crossref record; 160 of the 161 references it cites were found in a registry or an index.
Systematic Review: Comparative Effectiveness of Treatments to Prevent Fractures in Men and Women with Low Bone Density or Osteoporosis
Abstract
BACKGROUND: Although several agents are available to treat osteoporosis, the relative efficacy and toxicity of these agents when used to prevent fractures has not been well described. PURPOSE: To compare the benefits in fracture reduction and the harms from adverse events of various therapies for osteoporosis. DATA SOURCES: MEDLINE (1966 to November 2007) and other selected databases were searched for English-language studies. STUDY SELECTION: For the efficacy analysis, investigators selected studies that reported the rate of or risk for fractures. For the adverse event analysis, they selected studies that reported the relationship between an agent and cardiovascular, thromboembolic, or upper gastrointestinal events; malignant conditions; and osteonecrosis. DATA EXTRACTION: Using a standardized protocol, investigators abstracted data on fractures and adverse events, agents and comparators, study design, and variables of methodological quality. DATA SYNTHESIS: Good evidence suggests that alendronate, etidronate, ibandronate, risedronate, zoledronic acid, estrogen, parathyroid hormone (1-34), and raloxifene prevent vertebral fractures more than placebo; the evidence for calcitonin was fair. Good evidence suggests that alendronate, risedronate, and estrogen prevent hip fractures more than placebo; the evidence for zoledronic acid was fair. The effects of vitamin D varied with dose, analogue, and study population for both vertebral and hip fractures. Raloxifene, estrogen, and estrogen-progestin increased the risk for thromboembolic events, and etidronate increased the risk for esophageal ulcerations and gastrointestinal perforations, ulcerations, and bleeding. LIMITATION: Few studies have directly compared different agents or classes of agents used to treat osteoporosis. CONCLUSION: Although good evidence suggests that many agents are effective in preventing osteoporotic fractures, the data are insufficient to determine the relative efficacy or safety of these agents.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Affected trial reports were cited in nine effectiveness reviews and clinical guidelines (one published in Scotland, the others in the USA), for stroke,49 fracture prevention50–55 and fall and injury prevention.56”
From An investigation into the impact and implications of published papers from retracted research: systematic search of affected literature (2019) · cites this paper as [52]
In the citing paper
“Removing these affected trial reports would likely alter findings in five reviews and guidelines.51–54 56”
From An investigation into the impact and implications of published papers from retracted research: systematic search of affected literature (2019) · cites this paper as [52]
In the citing paper
“The publication in the Annals of Internal Medicine 52 from this AHRQ review has been cited 346 times, including September 2018, and it references four of the six above-mentioned affected trial reports, with these reports being the sole sources of data evidencing the reduction in fractures from bisphosphonates in patients with Parkinson’s disease, Alzheimer’s disease or stroke.”
From An investigation into the impact and implications of published papers from retracted research: systematic search of affected literature (2019) · cites this paper as [52]
Citations
Cites
10 retracted
Sato, Y., Iwamoto, J., Kanoko, T., & Satoh, K. (2005) · Cerebrovascular Diseases · doi:10.1159/000087203 · Cited by 410
RetractedWimalawansa, S. J. (1998) · The American Journal of Medicine · doi:10.1016/s0002-9343(98)00029-1 · Cited by 186
RetractedSato, Y., Iwamoto, J., Kanoko, T., & Satoh, K. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.15.1743 · Cited by 139
RetractedIshida, Y., & Kawai, S. (2004) · The American Journal of Medicine · doi:10.1016/j.amjmed.2004.05.019 · Cited by 127
RetractedRisedronate therapy for prevention of hip fracture after stroke in elderly women [RETRACTED]
(2005) · Neurology · doi:10.1212/01.wnl.0000152871.65027.76 · Cited by 81
RetractedSato, Y., Kanoko, T., Satoh, K., & Iwamoto, J. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.15.1737 · Cited by 69
RetractedSatō, Y., Asoh, T., Kaji, M., & Ōizumi, K. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.12.2487 · Cited by 63
RetractedSato, Y., Iwamoto, J., Kanoko, T., & Satoh, K. (2006) · Movement Disorders · doi:10.1002/mds.20825 · Cited by 56
RetractedBeneficial Effect of Etidronate Therapy in Immobilized Hip Fracture Patients[Retracted]
Satō, Y., Kanoko, T., Yasuda, H., Satoh, K., & Iwamoto, J. (2004) · American Journal of Physical Medicine & Rehabilitation · doi:10.1097/01.phm.0000122877.28631.23 · Cited by 21
RetractedSatō, Y., Honda, Y., & Iwamoto, J. (2006) · Bone · doi:10.1016/j.bone.2006.04.025 · Cited by 20
Retracted
Research works printed but not linked: 20
- Cranney A, 2001, Cochrane Database Syst Rev, CD003376
- Cranney A, 2000, Cochrane Database Syst Rev, CD001983
- Avenell A, 2005, Cochrane Database Syst Rev, CD000227
- Palmer S, 2005, Cochrane Database Syst Rev, CD005015
- Bone HG, 2000, J Clin Endocrinol Metab, 85, 720
- Sato S, 2003, J Rheumatol, 30, 2673
- Homik J, 2000, Cochrane Database Syst Rev, CD001347
- Reid IR, 1994, J Clin Endocrinol Metab, 79, 1595
- Homik JE, 1999, J Rheumatol, 26, 1148
- Muscoso E, 2004, Eur Rev Med Pharmacol Sci, 8, 97
- 10.1359/jbmr.2003.18.1.9 · DOI · Paper page
- Blair MM, 2000, J Fam Pract, 49, 839
- 10.1002/1529-0131(200101)44:1<202::AID-ANR27>3.0.CO;2-W · doi:10.1002/1529-0131(200101)44:1<202::aid-anr27>3.0.co;2-w
- 10.1002/1529-0131(199911)42:11<2309::AID-ANR8>3.0.CO;2-K · DOI · Paper page
- Cortet B, 1999, Rev Rhum Engl Ed, 66, 214
- Zheng S, 2003, Chin Med J (Engl), 116, 1127
- 10.1210/jcem.87.3.8325 · doi:10.1210/jcem.87.3.8325 · Paper page
- Meunier PJ, 1997, J Clin Endocrinol Metab, 82, 2784
- Silberstein EB, 1992, J Nucl Med, 33, 1
- Geusens P, 1997, Bone, 20, 9S
Cited by
MacLeod, A. M. (2009) · Kidney International · Cited by 2,218
Calcium plus Vitamin D Supplementation and the Risk of Fractures
Jackson, R. D., LaCroix, A. Z., Gass, M., Wallace, R. B., Robbins, J., Lewis, C. E., Bassford, T., Beresford, S. A. A., Black, H. R., Blanchette, P., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055218 · Cited by 1,883
Papaioannou, A., Morin, S., Cheung, A. M., Atkinson, S., Brown, J. P., Feldman, S., Hanley, D. A., Hodsman, A., Jamal, S. A., Kaiser, S. M., et al. (2010) · Canadian Medical Association Journal · doi:10.1503/cmaj.100771 · Cited by 1,749
for the IOF-IFCC Bone Marker Standards Working Group, Vasikaran, S., Eastell, R., Bruyère, O., Foldes, A. J., Garnero, P., Griesmacher, A., McClung, M., Morris, H. A., Silverman, S., et al. (2011) · Osteoporosis International · doi:10.1007/s00198-010-1501-1 · Cited by 1,212
The Patient Who Falls: “It's Always a Trade-off”
Tinetti, M. E., & Kumar, C. (2010) · JAMA · doi:10.1001/jama.2009.2024 · Cited by 982
Metadata
- Authors
- MacLean, C., Newberry, S., Maglione, M., McMahon, M., Ranganath, V., Suttorp, M., Mojica, W., Timmer, M., Alexander, A., McNamara, M., Desai, S. B., Zhou, A., Chen, S., Carter, J., Tringale, C., Valentine, D., Johnsen, B., & Grossman, J.
- Affiliations
- RAND Corporation (US)
- ORCID
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 2008-02-05
- Volume
- 148
- Issue
- 3
- Pages
- 197-213
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W2106649747
- Cited by
- 529
- References
- 161
- Citations by year
- 2026: 8 · 2025: 5 · 2024: 10 · 2023: 11 · 2022: 4 · 2021: 12 · 2020: 24 · 2019: 20 · 2018: 15 · 2017: 23 · 2016: 22 · 2015: 32 · 2014: 34 · 2013: 44 · 2012: 42
- FWCI
- 11.64
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.acpjournals.org/journal/aim/text-and-data-mining (tdm)
- Locations
- Annals of Internal Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Public Health Service (290-02-003)
- Topics
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
- Health Sciences › Medicine › Oncology › Bone health and treatments
- Keywords
- osteoporosis, osteoporotic fracture prevention, osteopenia, comparative effectiveness, bisphosphonates, alendronate, risedronate, zoledronic acid, etidronate, ibandronate, estrogen, raloxifene, parathyroid hormone, calcitonin, vitamin D, thromboembolic events, gastrointestinal adverse effects, vertebral fractures, hip fracture, sex differences
- MeSH terms
- Androgens, Calcium, Estrogens, Female, Humans, Male, Osteoporosis, Risk Factors, Testosterone, Vitamin D, Bone Density, Estrogen Replacement Therapy, Selective Estrogen Receptor Modulators, Bone Density Conservation Agents, Fractures, Bone
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Systematic Review: Comparative Effectiveness of Treatments to Prevent Fractures in Men and Women with Low Bone Density or Osteoporosis. https://app.cochat.ai/papers/10.7326/0003-4819-148-3-200802050-00198
- The paper
- MacLean, C., Newberry, S., Maglione, M., McMahon, M., Ranganath, V., Suttorp, M., Mojica, W., Timmer, M., Alexander, A., McNamara, M., Desai, S. B., Zhou, A., Chen, S., Carter, J., Tringale, C., Valentine, D., Johnsen, B., & Grossman, J. (2008). Systematic Review: Comparative Effectiveness of Treatments to Prevent Fractures in Men and Women with Low Bone Density or Osteoporosis. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-148-3-200802050-00198
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.